Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02120014 · ClinicalTrials.gov registry record · NA
Blood Volume and Hemodynamic Analysis in Patients With Chronic Heart Failure
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02120014: Completed NA study, sponsored by Mayo Clinic.
NCT02120014 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02120014, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary hypothesis is that patients with HFREF (heart failure with reduced ejection fraction) will demonstrate a markedly expanded intravascular volume which will correlate with elevated right heart hemodynamics and increased venous capacitance parameters, whereas patients with HFPEF(heart failure with preserved ejection fraction) will demonstrate euvolemia to mild volume expansion and a lack of correlation with hemodynamic and venous compliance parameters.
Interventions
- PROCEDURE blood volume measurement
- PROCEDURE venous plethysmography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-04-21 |
| Est. Completion | 2018-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02120014
The ClinicalTrials.gov registry entry for NCT02120014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which blood volume measurement is the first listed.
NCT02120014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02120014 about?
NCT02120014 is a clinical study titled "Blood Volume and Hemodynamic Analysis in Patients With Chronic Heart Failure". The primary hypothesis is that patients with HFREF (heart failure with reduced ejection fraction) will demonstrate a markedly expanded intravascular volume which will correlate with elevated right heart hemodynamics and increased venous capacitance parameters, whereas patients with HFPEF(heart failu...
What is the current status of trial NCT02120014?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2014-04-21. Estimated completion is 2018-07-06.
What interventions are being tested in trial NCT02120014?
The interventions under investigation include: blood volume measurement (PROCEDURE), venous plethysmography (PROCEDURE).
Who is sponsoring clinical trial NCT02120014?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.